All glucocorticoids Articles
- Concurrent lupus nephritis and Graves' disease improved with combined immunosuppression and methimazole in a single case
- Toripalimab can induce myositis, myocarditis, and thyroiditis in patients with non-small cell lung cancer
- Pembrolizumab-induced hypophysitis can cause arginine vasopressin deficiency unmasked by glucocorticoid therapy
- GPA with cranial involvement often presents as hypertrophic pachymeningitis and can mimic lung cancer metastasis
- 2024 ACR guidelines for lupus nephritis require caution in pediatric practice due to adult-derived evidence
- De novo immune checkpoint inhibitor-associated inflammatory arthritis occurs in 2.87% of patients in real-world cohorts
- Dermatomyositis with breast cancer regresses on glucocorticoids and paclitaxel in single case
- Thymectomy and immunotherapy improve symptoms in a patient with myasthenia gravis and paraneoplastic syndrome
- Impact of Heart Failure Medications and Ventilation on Duchenne Muscular Dystrophy Survival
- Precision glucocorticoid dosing remains investigational; genetic markers not yet clinically actionable
- Chemokine network emerges as rational lupus nephritis target as standard therapy fails 30% to 40%
- Tailor-made DMARD selection based on autoantibody status does not improve DAS scores in RA
- CAR T-cell therapy targeting CD19 or BCMA may induce sustained remission in specific autoimmune diseases
- Glucocorticoid signaling and stress-related neuroendocrine dysregulation influence intraocular pressure and inflammatory pathways in ocular diseases
- Glucocorticoid use and rheumatoid arthritis significantly increase vertebral fracture risk in postmenopausal women
- Mycophenolate mofetil combined with conventional therapy offers best balance of efficacy and safety
- Triple consolidation with CAR T cells yields sustained remission in relapsed BPDCN
- Metagenomic sequencing identifies Rickettsia felis encephalitis in a child who fully recovered
- Sintilimab may trigger autoimmune GFAP astrocytopathy in esophageal squamous cell carcinoma patients
- Evaluating Treat to Target Outcomes in Elderly and Young Rheumatoid Arthritis Patients
- Anatomical and immunological factors drive pathogenesis in plasma cell mastitis cases
- Ianalumab plus eltrombopag extends time to treatment failure in primary ITP adults
- Drug-induced osteoporosis mechanisms and gut microbiota links remain largely unresolved for most medication classes
- ERAS protocols may reduce opioid use and shorten stays for patients undergoing orthognathic surgery
- Brepocitinib 30 mg improved Total Improvement Score versus placebo in dermatomyositis patients over 52 weeks
- Stapokibart plus glucocorticoids achieves disease control in elderly bullous pemphigoid patients
- De-implementation of low-value bronchiolitis practices showed sustained adherence two years post-trial in a cluster RCT follow-up
- Baseline vitamin D deficiency occurred in 73.08% of TAO patients receiving IVGC therapy with calcium supplementation
- Protocol for natural experiment examining glucocorticoids versus no glucocorticoids on opioid use in hip and knee arthroplasty
- Expert review outlines diagnostic and therapeutic management strategies for eosinophilic granulomatosis with polyangiitis
- Meta-analysis links long-term glucocorticoid use and SLE duration to high osteoporosis prevalence in patients
- Interstitial lung disease reduces achievement of rheumatoid arthritis treatment goals over 24 months
- Japanese AAV Cohort Shows MPA Has 67.6% Five-Year Survival; Glucocorticoid Reduction Not Linked to Better Outcomes
- Phase 2 trial tests pre-hospital glucocorticoid pulse in STEMI patients undergoing primary PCI